Golden State Medical Supply Inc. Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.
Class II · Terminated
Mar 31, 2022
Mylan Pharmaceuticals Inc Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.
Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).